About PCAI
PCAI is a Healthcare company based in Toronto (Canada) founded in 2020 by Tyler Burpee, and was acquired by Osoyoos Cannabis in June 2020. Cannabis products are developed using artificial intelligence for therapeutic applications. Its focus areas include HealthTech, Cannabis HealthTech, Cannabinoid Therapeutics and Diversified. Its competitors include ZYUS Life Sciences, Avicanna and Aleafia Health; 2 of its 3 listed competitors have raised funding.
Company details
PCAI was founded in 2020 in Toronto, Canada, within the cannabis and biotechnology sector. Artificial intelligence is applied to create plant-based and fungal-based medicines, including pharmaceutical, nutraceutical, and cosmeceutical items derived from cannabis and psilocybin. Operations focus on treatments for conditions such as anxiety, ADHD, ulcerative colitis, Crohns disease, cancers, addictions, Alzheimers, depression, PTSD, Parkinsons, and related disorders.
- Headquarters Toronto, Canada
- Founders Tyler Burpee
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website pcai.ca
- Acquired by Osoyoos Cannabis (Jun 2020)
- Investors
- Acquired byOsoyoos Cannabis
(Jun 2020)
Investors in PCAI
PCAI has secured backing from 1 investor. Prominent investors backing the company include Osoyoos Cannabis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Cannabis extraction, processing, and licensing services are provided. | 2010 | osoyooscannabis.com | Toronto, Canada |
Investor details for PCAI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PCAI
1 people are tracked at PCAI (1 in leadership).
| Name | Role | Group |
|---|---|---|
Tyler Burpee | Co-Founder | Leadership |
Complete people profiles for PCAI
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PCAI
2 dated milestones of PCAI, from founding to its latest funding, stage changes and deals.
- Founded PCAI is founded.
- Exit Acquired by Osoyoos Cannabis.
Competitors of PCAI
PCAI has 3 listed competitors in our database, 2 of them funded. They include ZYUS Life Sciences, Avicanna and Aleafia Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| zyus.com | 2018 | Saskatoon, Canada | $19.5M | Cannabis-derived therapeutics for multiple indications are developed. | ||
| avicanna.com | 2016 | Toronto, Canada | $5.94M | Plant-derived cannabinoid products are developed for medical and consumer uses. | ||
| aleafiahealth.com | 2007 | Vaughan, Canada | Cultivator and producer of cannabis plant for consumer wellness and research applications |
Detailed competitors of PCAI
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cannabis Health Tech Ecosystem
2 companies that operate in the same segment as PCAI (Cannabis Health Tech Ecosystem) in Canada, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Cannabis products are provided to support consumer wellness and health. | 2013 | Smiths Falls, Ontario, Canada | USD 204.24 M | 960 | ||
Provider of cannabis products, brands, and international business development investments | 2013 | Moncton, New Brunswick, Canada | USD 186.16 M | 898 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PCAI
PCAI was founded in 2020.
PCAI is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
PCAI was founded in 2020 in Toronto, Canada, within the cannabis and biotechnology sector. Artificial intelligence is applied to create plant-based and fungal-based medicines, including pharmaceutical, nutraceutical, and cosmeceutical items derived from cannabis and psilocybin. Operations focus on treatments for conditions such as anxiety, ADHD, ulcerative colitis, Crohns disease, cancers, addictions, Alzheimers, depression, PTSD, Parkinsons, and related disorders.
PCAI's top competitors include Avicanna, ZYUS Life Sciences and Aleafia Health.
PCAI has 1 investor. Key investors include Osoyoos Cannabis.
Yes. PCAI was acquired by Osoyoos Cannabis in June 2020.